...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy
【24h】

Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy

机译:基于多目标策略的X原酮衍生物的设计,合成与抗阿尔茨海默病活性研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A series of xanthone derivatives were designed, synthesized and evaluated as multifunctional ligands against Alzheimer's disease (AD). In vitro studies showed all xanthone derivatives had good metal chelating property and exhibited selective inhibitory activity against Acetylcholinesterase (AChE). In particular, compound 2a showed the highest inhibitory activity against AChE, and the IC50 value was (0.328 +/- 0.001) mu M, which was comparable to tacrine. Kinetic analysis and molecular docking studies indicated that these derivatives targeted both the catalytically active site (CAS) and the peripheral anion site (PAS) of AChE. Moreover, all derivatives showed higher anti-oxidative activity than vitamin C. Furthermore, copper complex had higher anti-AChE activity and antioxidant activity. Thus, these xanthone derivatives are potential multi-targeted-directed ligands for further development for the treatment of AD.
机译:设计了一系列X吨酮衍生物,合成并评估为针对阿尔茨海默病(AD)的多功能配体。 体外研究表明,所有X原酮衍生物都具有良好的金属螯合性能,并针对乙酰胆碱酯酶(ACHE)表现出选择性抑制活性。 特别地,化合物2a显示出对疼痛的最高抑制活性,并且IC 50值为(0.328 +/- 0.001)mu m,其与甲锭相当。 动力学分析和分子对接研究表明,这些衍生物靶向催化活性位点(CAS)和疼痛的周围阴离子位点(PAS)。 此外,所有衍生物都表现出比维生素C更高的抗氧化活性。此外,铜络合物具有更高的抗疼痛活性和抗氧化活性。 因此,这些X吨酮衍生物是潜在的多目标定向配体,用于进一步用于治疗AD的开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号